Canada: For Your Phase 3 Global Trial Expansion
Oncology continues to be the largest and fastest growing therapeutic area in the clinical trials market, and a market dominated…
Oncology continues to be the largest and fastest growing therapeutic area in the clinical trials market, and a market dominated…
With agility increasingly becoming the most important global driver of success, it’s worth noting that Canadian oncology research center Phase…
It’s worth your time to consider whether or not the commonly held belief that using a larger CRO for your…
It’s no surprise that an underperforming site can cause significant delays in meeting important accrual targets, data timelines, or study…
The Global Clinical Trials Market was valued at $44.3B USD in 2020, and by 2028 is expected to reach $69.3B…
Canada is considered one of the most attractive places to live in the world, with a high quality of life,…
Developing oncology compounds is a constantly evolving process, and never more so than now. Pre-pandemic oncology was both the largest…
Pre-pandemic oncology was both the largest and fastest growing therapeutic area in the clinical trials market. A key market trend…
Participant diversity in clinical trials can be quite challenging to achieve. With COVID the concern about appropriate demographic representation is…
With the emergence of basket trials in the early-phase oncology setting, clinical research teams are faced with challenges of enrollment…